Form 8-K - Current report:
SEC Accession No. 0001079973-25-001264
Filing Date
2025-08-13
Accepted
2025-08-13 16:21:58
Documents
15
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 29365
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 168066
3 GRAPHIC image_001.jpg GRAPHIC 2804
  Complete submission text file 0001079973-25-001264.txt   435219

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE toi-20250813.xsd EX-101.SCH 3911
5 XBRL DEFINITION FILE toi-20250813_def.xml EX-101.DEF 26803
6 XBRL LABEL FILE toi-20250813_lab.xml EX-101.LAB 37032
7 XBRL PRESENTATION FILE toi-20250813_pre.xml EX-101.PRE 25427
17 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 251211994
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)